Larvol Delta - BiomX-Announces-Completion-of-Patient-Dosing-in-Part-2-of-the-Phase-1b2a-Study-Evaluating-BX004-for-Treatment-of-Chronic-Pulmonary-Infections-in-Patients-with-Cystic-Fibrosis

BX004 - BiomX

https://www.globenewswire.com/news-release/2023/10/04/2754399/0/en/BiomX-Announces-Completion-of-Patient-Dosing-in-Part-2-of-the-Phase-1b-2a-Study-Evaluating-BX004-for-Treatment-of-Chronic-Pulmonary-Infections-in-Patients-with-Cystic-Fibrosis.html

Oct 4, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next